Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact

被引：0
|
作者：
Pei, Charles [1 ]
Blackburn, Lisa [2 ]
Sharma, Nidhi [3 ]
Bumma, Naresh [4 ]
Khan, Abdullah Mohammad [5 ]
Devarakonda, Srinivas [6 ]
Umyarova, Elvira [7 ]
Benson, Don [8 ]
Rosko, Ashley [9 ]
El Boghdadly, Zeinab [10 ]
Cottini, Francesca [9 ]
机构：
[1] Ohio State Univ, Coll Med, Columbus, OH USA
[2] Ohio State Univ, Coll Med, Columbus, OH USA
[3] Ohio State Univ, Med Ctr, Div Hematol, Columbus, OH USA
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[5] Ohio State Univ, Div Hematol, Columbus, OH USA
[6] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH USA
[7] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Hematol, Columbus, OH USA
[8] Ohio State Univ, Med Ctr, Columbus, OH USA
[9] Ohio State Univ, Columbus, OH USA
[10] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Div Infect Dis, Columbus, OH USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-201519
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4717 / 4718
页数：2
相关论文
共 50 条
  • [41] Clinical risk factors for cytomegalovirus retinitis in patients with AIDS
    Hodge, WG
    Boivin, JF
    Shapiro, SH
    Lalonde, RG
    Shah, KC
    Murphy, BD
    Dionne, MA
    Goela, A
    OPHTHALMOLOGY, 2004, 111 (07) : 1326 - 1333
  • [42] The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
    Evans, Laura A.
    Go, Ronald S.
    Nandakumar, Bharat
    Buadi, Francis K.
    Dispenzieri, Angela
    Dingli, David
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Kapoor, Prashant
    Leung, Nelson
    Fonder, Amie
    Hobbs, Miriam A.
    Hwa, Yi L.
    Muchtar, Eli
    Warsame, Rahma M.
    Kourelis, Taxiarchis
    Russell, Stephen J.
    Lust, John A.
    Siddiqui, Mustaqeem
    Kyle, Robert A.
    Gertz, Morie A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    Gonsalves, Wilson I.
    BLOOD, 2019, 134
  • [43] Risk Factors and Risk Stratification of Thromboembolic Risk in Patients with Multiple Myeloma
    Chaireti, Roza
    Nahi, Hareth
    Mazzucato, Mario
    HEMATO, 2022, 3 (03): : 518 - 526
  • [44] Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine
    Huang, Jen-Pei
    Yeh, Chiu-Mei
    Gong, Ya-Wen
    Tsai, Ming-Hsuan
    Lin, Yi-Tsung
    Tsai, Chun-Kuang
    Liu, Chia-Jen
    ANNALS OF HEMATOLOGY, 2024, 103 (10) : 4099 - 4109
  • [45] Risk factors for renal impairment in patients with solid tumors or multiple myeloma treated with zoledronic acid
    Cha, You Jin
    Lee, Yu Jeung
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (04) : 274 - 282
  • [46] Clinical Characteristics and Predictive Factors of Peripheral Neurophaty in Multiple Myeloma Patients Treated with Bortezomib and/or Imids
    Federico, Vincenzo
    Eleonora, Russo
    Truini, Andrea
    Levi, Anna
    Gentilini, Fabiana
    Biagioli, Giulia
    Leoni, Caterina
    Foa, Robin
    Petrucci, Maria Teresa
    BLOOD, 2012, 120 (21)
  • [47] Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis
    Sharpley, Faye A.
    De-Silva, Dunnya
    Mahmood, Shameem
    Sachchithanantham, Sajitha
    Ramsay, Isobel
    Mingo, Ana Garcia
    Worthington, Sarah
    Hughes, Derralynn
    Mehta, Atul
    Kyriakou, Charalampian
    Griffiths, Paul D.
    Wechalekar, Ashutosh D.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (03) : 230 - 235
  • [48] Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment
    Frerichs, Kristine A.
    Bosman, Patricia W. C.
    Nijhof, Inger S.
    Zweegman, Sonja
    van de Donk, Niels W. C. T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (01): : E9 - E11
  • [49] Clinical impact of the CONUT score in patients with multiple myeloma
    Okamoto, Sho
    Ureshino, Hiroshi
    Kidoguchi, Keisuke
    Kusaba, Kana
    Kizuka-Sano, Haruna
    Sano, Haruhiko
    Nishioka, Atsujiro
    Yamaguchi, Kyosuke
    Kamachi, Kazuharu
    Itamura, Hidekazu
    Yoshimura, Mariko
    Yokoo, Masako
    Shindo, Takero
    Kubota, Yasushi
    Ando, Toshihiko
    Kojima, Kensuke
    Kawaguchi, Atsushi
    Sueoka, Eisaburo
    Kimura, Shinya
    ANNALS OF HEMATOLOGY, 2020, 99 (01) : 113 - 119
  • [50] Risk of RBC alloimmunization in multiple myeloma patients treated by Daratumumab
    Ye, Zhan
    Wolf, Laurie A.
    Mettman, Daniel
    Plapp, Fred, V
    VOX SANGUINIS, 2020, 115 (02) : 207 - 212
12345